CELECOXIB-D7
CELECOXIB-D7 Basic information
- Product Name:
- CELECOXIB-D7
- Synonyms:
-
- CELECOXIB-D7
- 4-[5-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
- [2H7]-Celecoxib
- Celecoxib D7Q: What is Celecoxib D7 Q: What is the CAS Number of Celecoxib D7 Q: What is the storage condition of Celecoxib D7 Q: What are the applications of Celecoxib D7
- Celecoxiβ-d7
- 4-[5-[4-(methyl-d3)phenyl-2,3,5,6-d4]-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide
- D7-Celecoxib
- CAS:
- 544686-21-7
- MF:
- C17H7D7F3N3O2S
- MW:
- 388.42
- Mol File:
- Mol File
CELECOXIB-D7 Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- DMSO: 76 mg/ml,Ethanol: 33 mg/ml
- form
- A solid
- color
- Off-white to gray
CELECOXIB-D7 Usage And Synthesis
Description
Celecoxib-d7 is intended for use as an internal standard for the quantification of celecoxib by GC- or LC-MS. Celecoxib is a selective inhibitor of COX-2 (IC50s = 22.9 and 0.05 μM for COX-1 and COX-2, respectively). It displays chemopreventive activity in multiple tumor types via proapoptotic effects that are independent of COX-2 inhibition. Formulations containing celecoxib have been used in the treatment of inflammation while circumventing the gastrointestinal toxicity associated with traditional non-sterodial anti-inflammatory drugs, however, the use of celecoxib has been tempered due to its ability to induce adverse cardiovascular events.
Uses
Celecoxib-d7 is the labeled analogue of Celecoxib (C251000), a selective cyclooxygenase-2 (COX-2) inhibitor. Anti-inflammatory. Used in treatment of familial adenomatous polyposis.
References
[1] MD.JASHIM UDDIN Edward E K P N Praveen Rao. Design and synthesis of novel celecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the sulfonamide pharmacophore by a sulfonylazide bioisostere[J]. Bioorganic & Medicinal Chemistry, 2003, 11 23: Pages 5273-5280. DOI: 10.1016/j.bmc.2003.07.005
[2] I A MARDINI G A F. Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs.[J]. Molecular interventions, 2001, 1 1: 30-38.
[3] VERENA JENDROSSEK Claus B René Handrick. Celecoxib activates a novel mitochondrial apoptosis signaling pathway[J]. FASEB Journal, 2003, 17 11: 1-25. DOI: 10.1096/fj.02-0947fje
[4] De Souza, F.I., Zumiotti, A.V., and Da Silva, C.F. Neuregulins 1-α and 1-β on the regeneration the peripheral nerves[J]. Acta Ortop Bras.
[5] JIUXIANG ZHU. From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors.[J]. Cancer research, 2004, 64 12: 4309-4318. DOI: 10.1158/0008-5472.can-03-4063
CELECOXIB-D7Supplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- +91-22-26355700
- info@clearsynth.com
- Tel
- 020-81960175
- min.he@cato-chem.com
- Tel
- 0755-0755-66853366 13670046396
- sales@chem-strong.com
- Tel
- 021-61537865 13585780846
- sales@champchem.com